2023 Q2 Form 10-Q Financial Statement

#000157587223000819 Filed on May 22, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.890K $115.5K $0.00
YoY Change -100.0%
Cash & Equivalents $2.885K $115.5K $0.00
Short-Term Investments
Other Short-Term Assets $221.2K
YoY Change 34454.69%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $2.890K $115.5K $221.2K
YoY Change -98.94% -47.77% 4064.78%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill $2.832M $2.832M
YoY Change -62.24%
Intangibles $8.968M $8.968M
YoY Change -62.63%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $11.80M $11.80M $31.50M
YoY Change -62.54% -62.54%
TOTAL ASSETS
Total Short-Term Assets $2.890K $115.5K $221.2K
Total Long-Term Assets $11.80M $11.80M $31.50M
Total Assets $11.80M $11.92M $31.72M
YoY Change -62.85% -62.44% 597285.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.124M $1.160M $34.50K
YoY Change 2214.19% 3261.3% 666.67%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.608M $1.757M $604.7K
YoY Change 140.03% 190.55% 2282.66%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.608M $1.757M $604.7K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.608M $1.757M $604.7K
YoY Change 140.03% 190.55% 2282.66%
SHAREHOLDERS EQUITY
Retained Earnings -$28.63M -$26.24M
YoY Change 1261.25%
Common Stock $134.1K $124.6K
YoY Change 274.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.20M $10.16M $31.12M
YoY Change
Total Liabilities & Shareholders Equity $11.80M $11.92M $31.72M
YoY Change -62.85% -62.44% 597285.12%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001746278
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
333-231286
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
GoLogiq, Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
35-2618297
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
230 Victoria Street Bugis Junction
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
#15-01/08
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Singapore
CY2023Q1 dei Entity Address Country
EntityAddressCountry
SG
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
188024
CY2023Q1 dei City Area Code
CityAreaCode
65
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
9366 2322
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
129677156
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
115498
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35254
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8968000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8968000
CY2023Q1 us-gaap Goodwill
Goodwill
2832000
CY2022Q4 us-gaap Goodwill
Goodwill
2832000
CY2023Q1 us-gaap Assets
Assets
11915498
CY2022Q4 us-gaap Assets
Assets
11835254
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1159651
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1321483
CY2023Q1 us-gaap Due To Other Related Parties Noncurrent
DueToOtherRelatedPartiesNoncurrent
597385
CY2022Q4 us-gaap Due To Other Related Parties Noncurrent
DueToOtherRelatedPartiesNoncurrent
788045
CY2023Q1 us-gaap Liabilities
Liabilities
1757036
CY2022Q4 us-gaap Liabilities
Liabilities
2109528
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
124609635
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
124609635
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40444083
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40444083
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
124610
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
40444
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2000000
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2000000
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2000000
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2000000
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
2000
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
2000
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
36273995
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
34003212
CY2023Q1 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
58
CY2022Q4 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
58
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-26242085
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-24319872
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
10158462
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
9725726
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11915498
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11835254
CY2023Q1 us-gaap Revenues
Revenues
71916
CY2022Q1 us-gaap Revenues
Revenues
3309017
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
38645
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
2235341
CY2023Q1 us-gaap Gross Profit
GrossProfit
33271
CY2022Q1 us-gaap Gross Profit
GrossProfit
1073676
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1900484
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1368799
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5000
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
55000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1090500
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
1955484
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
2464299
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1922213
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1390623
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1922213
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1390623
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.037
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.052
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51477398
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26637863
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
9725726
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2347720
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
7229
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1922213
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
10158462
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-42643
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
32549695
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1390623
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
31116429
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1922213
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1390623
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
220801
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-90580
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
14000
CY2023Q1 golq Increase Decrease In Issuance Of Shares For Service Received
IncreaseDecreaseInIssuanceOfSharesForServiceReceived
2354948
CY2022Q1 golq Increase Decrease In Issuance Of Shares For Service Received
IncreaseDecreaseInIssuanceOfSharesForServiceReceived
780000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
342155
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-817424
CY2023Q1 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-261911
CY2022Q1 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
547729
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-261911
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
547729
CY2022Q1 golq Costs Arising From Transitional Arrangements
CostsArisingFromTransitionalArrangements
269695
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
269695
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
80244
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35254
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
115498
CY2023Q1 us-gaap Stock Issued1
StockIssued1
1807268
CY2022Q1 us-gaap Stock Issued1
StockIssued1
780000
CY2023Q1 us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 1 – Nature of Business and Continuance of Operations</div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">GoLogiq, Inc. (formerly known as Lovarra) (the “Company”) was incorporated on January 29, 2018 under the laws of the State of Nevada. As of December 31, 2021, the Company was a shell company focused on software application development, including an expense and income tracker and a physical wallet with a lock that can be opened via Bluetooth linked by a user application. On January 27, 2022, the Company completed the acquisition of the business segment of CreateApp from Logiq Inc. (a fully reporting public company) (“Logiq”). As a result, the Company’s results of operations for the year ended December 31, 2022 include the operations of CreateApp.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">On May 9, 2022, the Company changed its name from Lovarra Inc. to GoLogiq, with the Secretary of State of the State of California, and on June 9, 2022, the Company’s common stock began trading on the OTC Markets marketplace under the Company’s new name, GoLogiq, Inc., and the new ticker symbol “GOLQ.”</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">On July 27, 2022, Logiq completed the spin off of its direct interests in the Company, in connection with which Logiq distributed an aggregate of 26,350,756 shares of the Company’s common stock then directly owned by Logiq to Logiq’s stockholders of record as of December 30, 2021 on a 1-for-1 basis (i.e. for every 1 share of Logiq held on December 30, 2021, the holder thereof received 1 share of the Company). As a result of the completion of the spin off, as of July 27, 2022, the Company is no longer a majority owned subsidiary of Logiq.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">As of March 31, 2023, Logiq controlled, through one of its subsidiaries, approximately 3.61% of the Company’s outstanding shares of common stock and voting power of the Company’s outstanding securities.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">As a result of the CreateApp acquisition, the Company ceased to be a shell company (as defined in Rule 12b-2 of the Act), and the Company’s primary business is now that of the CreateApp business. As a result of the CreateApp business acquisition, the Company now offers solutions that help small-to-medium-sized businesses (“SMBs”) to provide access to and reduce transaction friction of e-commerce for their clients globally. The Company’s solutions are provided through its core platform, operated as CreateApp (https://www.createapp.com/), which allows SMBs to establish their point-of-presence on the web.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s CreateApp platform enables SMBs to create a mobile app for their business without the need of technical knowledge, high investment, or background in IT by utilizing CreateApp, which is a platform that is offered as a Platform as a Service (“PaaS”). The Company provides its PaaS to SMBs in a wide variety of industry sectors.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">Management believes the assumptions underlying the condensed financial statements are reasonable. However, the amounts recorded for the Company’s related party transactions with Logiq and its consolidated subsidiaries may not be considered arm’s length with an unrelated third party. Therefore, the condensed financial statements included herein may not necessarily reflect the results of operations, financial position and cash flows had the Company engaged in such transactions with an unrelated third party during all periods presented. Accordingly, the Company’s historical financial information is not necessarily indicative of what the Company’s results of operations, financial position and cash flows will be in the future, if and when the Company contracts at arm’s length with unrelated third parties for products and services the Company receives from and provides to Logiq.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Going Concern</div></div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">These financial statements have been prepared on the going concern basis, which assumes that the Company will be able to realize its assets and discharge its liabilities in the normal course of business. The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholders, the ability of the Company to obtain necessary equity financing to support operations, and the attainment of profitable operations.  During the three months ended March 31, 2023, the Company has incurred operating losses of ($1,922,213) and ($1,390,623)  from operating losses for the three months ended March 31, 2022. As at March 31, 2023, the Company has a working capital deficit of $1,641,538 and an accumulated deficit of ($26,242,085). These factors raise substantial doubt upon the Company’s ability to continue as a going concern. These financial statements do not reflect any adjustments that may be necessary if the Company is unable to continue as a going concern.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"/></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">On March 11, 2020, the World Health Organization declared COVID-19 a global pandemic. This contagious disease outbreak and any related adverse public health developments, has adversely affected workforces, economies, and financial markets globally, leading to an economic downturn and increased inflation in the United States. The impact on the Company was significant for the three months ended March 31, 2023 and fiscal 2022, but management continues to monitor the situation as more of the population in the region where we operate is vaccinated and business has begun returning to some normality. In addition, many of our customers are working remotely, which may delay the timing of new business and implementations of our services. If COVID-19 and/or inflation continues to have a substantial impact on our partners, customers, vendors, resellers, or suppliers, our results of operations and overall financial performance could be harmed.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div>
CY2022Q3 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
26350756
CY2023Q1 us-gaap Debt Instrument Description
DebtInstrumentDescription
1-for-1 basis
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1922213
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1390623
CY2023Q1 golq Working Capital
WorkingCapital
1641538
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-26242085
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates and Judgments</div></div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company applies judgment in the application of the going concern assumption which requires management to take into account all available information about the future, which is at least, but not limited to, 12 months from the end of the reporting period.</div></div>
CY2022Q2 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P5Y
CY2022Q1 us-gaap Debt Conversion Description
DebtConversionDescription
Logiq held the GoLogiq Shares until July 27, 2022, on which date it distributed 100% of the GoLogiq Shares to Logiq’s stockholders of record as of December 30, 2021 on a 1-for-1 basis
CY2022Q3 us-gaap Debt Instrument Redemption Price Percentage
DebtInstrumentRedemptionPricePercentage
0.25
CY2022Q3 golq Remaining Issuance Of Percentage
RemainingIssuanceOfPercentage
0.75
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
24000000
CY2023Q1 us-gaap Goodwill Gross
GoodwillGross
7500000
CY2023Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
31500000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
7229073
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.001
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
106666667
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
1
CY2023Q1 golq Percentage Of Common Shares Acquired
PercentageOfCommonSharesAcquired
1
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
77500000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
77500000
CY2023Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
29166667

Files In Submission

Name View Source Status
0001575872-23-000819-index-headers.html Edgar Link pending
0001575872-23-000819-index.html Edgar Link pending
0001575872-23-000819.txt Edgar Link pending
0001575872-23-000819-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gl007_ex31-1.htm Edgar Link pending
gl007_ex31-2.htm Edgar Link pending
gl007_ex32-1.htm Edgar Link pending
gl007_ex32-2.htm Edgar Link pending
golq-20230331.htm Edgar Link pending
golq-20230331.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
golq-20230331_def.xml Edgar Link unprocessable
golq-20230331_lab.xml Edgar Link unprocessable
golq-20230331_pre.xml Edgar Link unprocessable
golq-20230331_htm.xml Edgar Link completed
golq-20230331_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable